/

DPBIO

High-throughput droplet microfluidic solutions for antibody discovery and research

BiotechnologyLife Sciences dp-bio.com ↗

Company facts

Founded: 2018
Employees: 100
Headquarters: United States
Type: Private
Funding: Series B · $13.9M · 2024